TITLE

Comparative study of the intestinal mucus barrier in normal and inflamed colon

AUTHOR(S)
Swidsinski, Alexander; Loening-Baucke, Vera; Theissig, Franz; Engelhardt, Holger; Bengmark, Stig; Koch, Stefan; Lochs, Herbert; Dörffel, Yvonne
PUB. DATE
March 2007
SOURCE
Gut;Mar2007, Vol. 56 Issue 3, p343
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: To study the role of mucus in the spatial separation of intestinal bacteria from mucosa. Patients and methods: Mucus barrier characteristics were evaluated using histological material obtained by biopsy from purged colon, colon prepared with enema and material from untreated appendices fixed with non-aqueous Carnoy solution. Bacteria were evaluated using fluorescence in situ hybridization, with bacterial 1 6S RNA probes and related to the periodic acid Schiff alcian blue stain. Biopsies from controls (n = 20), patients with self-limiting colitis (SLC; n = 20), ulcerative colitis (n = 20) and 60 randomly selected appendices were investigated. Results: The mucosal surface beneath the mucus layer was free of bacteria in ⩾80% of the normal appendices and biopsies from controls. The thickness of the mucus layer and its spread decreased with increasing severity of the inflammation; the epithelial surface showed bacterial adherence, epithelial tissue defects and deep mucosal infiltration with bacteria and leucocytes. Bacteria and leucocytes were found within mucus in all biopsy specimens from patients with ulcerative colitis, SLC, and acute appendicitis. The concentration of bacteria within mucus was inversely correlated to the numbers of leucocytes. Conclusions: The large bowel mucus layer effectively prevents contact between the highly concentrated luminal bacteria and the epithelial cells in all parts of the normal colon. Colonic inflammation is always accompanied by breaks in the mucus barrier. Although the inflammatory response gradually reduces the number of bacteria in mucus and faeces, the inflammation itself is not capable of preventing bacterial migration, adherence to and invasion of the mucosa.
ACCESSION #
24528559

 

Related Articles

  • Introduction: Mucosal Immunology Special issue. Takeda, Kiyoshi // International Immunology;Sep2014, Vol. 26 Issue 9, p479 

    No abstract available.

  • ANTI-INFLAMMATORY EFFECT OF N-ACETYLCYSTEINE (NAC) IN A MODEL OF COLITIS. Azooz, O.G.; De Silva, A.; Rampton, D.S.; Ballinger, A.B. // Gut;Apr2003 Supplement 1, Vol. 52, pA61 

    Introduction: Oxidative stress is a potential mechanism in the pathogenesis of inflammatory bowel disease (IBD) where reactive oxygen species (ROS) ore produced in excess by the intestinal mucosa. N-acetylcysteine (NAC) is a synthetic thiol compound which has antioxidant properties and...

  • Mucosal Invasion by Fusobacteria is a Common Feature of Acute Appendicitis in Germany, Russia, and China. Swidsinski, Alexander; Dorffel, Yvonne; Loening-Baucke, Vera; Tertychnyy, Alexander; Biche-ool, Salbakay; Stonogin, Sergei; Guo, Yi; Sun, Ning-Dong // Saudi Journal of Gastroenterology;Jan2012, Vol. 18 Issue 1, p55 

    Background/Aim: To investigate the geographic occurrence of mucosa-invading Fusobacteria in acute appendicitis. Patients and Methods: Carnoy- and formalin-fixated appendices from Germany, Russia, and China were comparatively investigated. Bacteria were detected using fluorescent in situ...

  • Decreased Incorporation of 14C-Glucosamine Relative to 3H-N-Acetyl Glucosamine in the Intestinal Mucosa of Patients with Inflammatory Bowel Disease. Burton, A. F.; Anderson, F. H. // American Journal of Gastroenterology;Jan1983, Vol. 78 Issue 1, p19 

    The synthesis of glycoproteins was investigated in intestinal mucosa from patients with inflammatory bowel disease (IBD) and from those with various other conditions. The incorporation into acid-insoluble macromolecules of the amino sugar glucosamine, the first and committed metabolite in the...

  • Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease. Mitsuyama, Keiichi; Yamasaki, Hiroshi; Kuwaki, Kotaro; Takedatsu, Hidetoshi; Sata, Michio // Current Pharmaceutical Design;6/21/2009, Vol. 15 Issue 18, p2110 

    Inflammatory bowel disease (IBD) is frequently associated with the infiltration of a large number of leukocytes into the bowel mucosa. Therefore, the removal of circulating leukocytes may be an attractive approach for the treatment of IBD. Leukocytapheresis with Cellsorba, a column of...

  • Site of Origin of Dysplastic Epithelium in Colonic Mucosa. LEV, ROBERT; GUANG-YU YANG // Archives of Pathology & Laboratory Medicine;May2014, Vol. 138 Issue 5, p583 

    A letter to the editor and a reply are presented in response to the article "Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology," by K. A. Matkowskyj, Z. E. Chen, M. S. Rao, and G. Y. Yang in the 2013 issue.

  • Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease? Kruidenier, L.; Verspaget, H. W. // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p157 

    OXIDATIVE damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be...

  • Immune-non Immune Networks in Intestinal Inflammation. Hausmann, Martin; Rogler, Gerhard // Current Drug Targets;May2008, Vol. 9 Issue 5, p388 

    The intestinal mucosa forms a primary barrier providing both barrier function and immediate effective recognition of bacterial products invading the mucosa. This is of great importance for the prevention of permanent and chronic inflammation as a reaction to the commensal intestinal flora and...

  • Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. Akazawa, Akiko; Sakaida, Isao; Higaki, Shingo; Kubo, Yoshitsugu; Uchida, Koichi; Okita, Kiwamu // Journal of Gastroenterology;2002, Vol. 37 Issue 5, p345 

    Background: Tumor necrosis factor-α (TNF-α), may be involved in the pathogenesis of inflammatory bowel diseases (IBDs). The aim of this study was to evaluate the effect of TNF-α on the inflammatory activity of IBD. Methods: TNF-α mRNA expression in intestinal mucosal biopsy specimens...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics